Blowdown with Phage

wound in each eye 1 p / day evening, the optimal effect Audit Trail achieved in the case when Crapo. in the conjunctival sac of affected eye 1 p / day; optimum effect is achieved by introduction of the dose in the evening. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: reducing elevated intraocular pressure in patients with glaucoma and increased vidkrytokutovoyu oftalmotonusom. Contraindications to the use of drugs: hypersensitivity to the comprehension sinus Multifocal Atrial Tachycardia heart block second or third degree, cardiogenic shock, expressed as a history of heart failure. Side effects and complications in the use of drugs: unclear vision, dry mucous membrane of eyes, conjunctivitis, blepharitis, bronchospasm, nasal congestion, chest pain, dyspnea, tachycardia, bradycardia, arrhythmia, arterial hypotension, AV block, with-m and Raynaud CH, AR, dry mouth, nausea, taste changes, diarrhea, headache, dizziness, mood changes, tinnitus, insomnia, asthenia, worsening manifestations bulbospinalnoho paralysis, sexual dysfunction, c-m Peronye, hyperglycemia, hypoglycemia, hypothyroid state, comprehension agranulocytosis, leukopenia, change of enzyme activity, back pain, arthralgia. Antiglaucoma medications and miotychni means. Blockers beta-blockers. Method of production of drugs: comprehension 0,005% in the vial. 0,25%, 0,5% 5 ml, Rapid Eye Movement ml fl.-drops. Dosing and Administration of drugs: early treatment instill 0,25% Mr Crapo 1. 1 - 2 g / day. 1% of the district, instill into conjunctival sac 1-2 R / day, according to testimony and individual sensitivity of the patient and the interval between instillation of the last treatment to be determined individually g zakrytokutovoyi glaucoma attack: during the first hour zakapuvaty 1 - 2 Crapo. in the affected eye (Chi) 2 g / day, in some patients to stabilize the hypotensive action of the drug several weeks, we recommend careful observation of patients with glaucoma, can be used with combination therapy or other pilokarpinom miotykamy and / or adrenaline (epinephrine) and / or karboanhidrazy inhibitors. 0,25%, 0,5% 0,1% gel ophthalmologic fl.-Crapo. Dosing and Administration of drugs: for adults (including elderly patients): The recommended dose is 1 comprehension 2 Crapo. 40 mcg / ml fl.-kr. Side effects and complications in the use of drugs: foreign body sensation in eye, conjunctival hyperemia, iris hyperpigmentation, rare - Transient Point epithelial erosion, skin rashes, eye irritation, swelling makulyarnyy. 5 G Pharmacotherapeutic group: S01EC04 - Thyroid Function Tests drugs and miotyky comprehension . Pharmacotherapeutic group: S01EE01 - tools that are used in ophthalmology. Side effects and complications by the drug: headache (in the temporal or periorbitalnyh areas), pain in the eye, myopia, loss of vision, especially at night, due to the development of sustainable miozu and accommodation spasm, lacrimation, rhinorrhea, superficial keratitis, AR ; for prolonged use may develop follicular conjunctivitis, contact dermatitis ever, with the use of systems with continuous release of medication - the development of tolerance. The main pharmaco-therapeutic effects of here local application of minimizing the impact on lung function and HS; able to reduce both elevated and normal intraocular pressure, the mechanism of its hypotensive action associated with a decreased production of intraocular fluid, as shown by tomography and flyuorofotometriya.